510(k) K862649
K862649 is an FDA 510(k) premarket notification submitted by Cytotech, Inc. for the device "CYTOTECH CIC ENZYME IMMUNOASSAY". The FDA issued a decision of Substantially Equivalent on September 4, 1986. The device falls under product code DAK (Complement C1q, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. Cytotech, Inc. has at least 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 4, 1986
- Date Received
- July 11, 1986
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C1q, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5240
- Review Panel
- IM
- Submission Type